Research Solutions (RSSS) director granted 60,000 stock options

Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant for 60,000 shares of common stock on 11/12/2025 at an exercise price of $3.07 per share.

Rhea-AI Filing Summary

Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant for 60,000 shares of common stock on 11/12/2025 at an exercise price of $3.07 per share. These stock options expire on 11/11/2035, giving the holder a long window to buy shares at that price if they choose.

The options vest over time. One-third of the grant vests on 11/12/2026, and the remaining two-thirds vest in equal installments on the last day of each quarter beginning 12/31/2026 until fully vested. Following this transaction, the reporting person directly holds 60,000 derivative securities (stock options) tied to Research Solutions common stock.

Insider Trade Summary

Grant/Award: 60,000 shares

Grant/Award 1 txn

Insider Regazzi John J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	60,000	$0.00	$0.00

Holdings After Transaction: Option to purchase common stock — 60,000 contracts (Direct)

Footnotes (1)

1. F1. 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Research Solutions (RSSS) disclose in this Form 4 filing?

The filing reports that a director of Research Solutions, Inc. (RSSS) received an option to purchase 60,000 shares of common stock at an exercise price of $3.07 per share on 11/12/2025.

What is the exercise price of the RSSS stock options granted?

The reported option grant has an exercise price of $3.07 per share for 60,000 shares of Research Solutions common stock.

How do the 60,000 RSSS stock options vest for the director?

According to the disclosure, 1/3 of the options vest on 11/12/2026, and 1/12 of the options vest on the last day of each quarter starting 12/31/2026 until the full 60,000 options are vested.

When do the newly granted RSSS stock options expire?

The option to purchase 60,000 shares of Research Solutions common stock has an expiration date of 11/11/2035.

What is the director’s beneficial ownership after this RSSS option grant?

After the reported transaction, the director beneficially owns 60,000 derivative securities (stock options) related to Research Solutions common stock, held as direct ownership.

What role does the reporting person have at Research Solutions (RSSS)?

The reporting person is identified as a Director of Research Solutions, Inc. as indicated in the relationship section of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/21/2025 - 04:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regazzi John J

(Last) (First) (Middle)

C/O RESEARCH SOLUTIONS, INC.

(Street)

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$3.07	11/12/2025		A		60,000		(1)	11/11/2035	Common Stock	60,000	$0	60,000	D

Explanation of Responses:

1. 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested.

	/s/ William Nurthen, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.